<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2602256946
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2025
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOMAX
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        160
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        141.20
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jazeera Pharmaceutical Industries (JPI)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)	
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Diclofenac sodium, the active ingredient in Diclomax, is one of a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs reduce pain and inflammation.</p><p>Diclomax relieve pain, reduce swelling and ease inflammation in conditions affecting the joints, muscles and tendons including:</p><ul><li>Rheumatoid arthritis, osteoarthritis, acute gout (painful inflammation of the joints especially in the feet and hands). ankylosing spondylitis (form of spinal arthritis).</li><li>Backache, sprains and strains, soft tissue sports injuries, frozen shoulder, dislocations and fractures</li><li>Conditions affecting the tendons for example, tendonitis, tenosynovitis, bursitis.</li></ul><p>They are also used to treat pain and inflammation associated with dental and minor surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Diclomax if: </strong></p><ul><li>You are allergic to diclofenac sodium, aspirin, ibuprofen or any other NSAID, or to any of the other ingredients of Diclomax (these are listed under section 6 &quot;contents of the pack and other information&quot; of the leaflet). Signs of a hypersensitivity reaction include swelling of the face and mouth (angioedema), breathing problems, chest pain, runny nose, skin rash or any other allergic type reaction.</li><li>You have now, or have ever had, a stomach (gastric) or duodenal (peptic) ulcer, or bleeding in the digestive tract (this can include blood in vomit, bleeding when emptying bowels, fresh blood in faeces or black, tarry faeces)</li><li>You have had stomach or bowel problems after you have taken other NSAIDs</li><li>You have severe heart, kidney or liver failure</li><li>You have established heart disease and/or cerebrovascular disease, e.g. if you have had a heart attack, stroke, mini-stroke (TIA) or blockages to blood vessels to the heart or brain or an operation to clear or bypass blockages.</li><li>You have or have had problems with your blood circulation (peripheral arterial disease)</li><li>You are more than six months pregnant</li></ul><p><strong>Warnings and precautions</strong><br />Talk to your doctor or pharmacist before taking diclofenac if:</p><ul><li>You suffer from any stomach or bowel disorders including ulcerative colitis or Crohn&rsquo;s disease</li><li>You have kidney or liver problems, or you are elderly</li><li>You have a condition called porphyria</li><li>You suffer from any blood or bleeding disorder. If you do, your doctor may ask you to go for regular check-ups while you are taking these tablets.</li><li>You ever had asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (nasal polyps), chronic pulmonary diseases or infections of the respiratory tract.</li><li>You are breast feeding</li><li>You have angina, blood clots, high blood pressure, raised cholesterol or raised triglycerides</li><li>You have heart problems or if you had a stroke or you think you might be at risk of these conditions (for example, if you have high blood pressure, diabetes or high cholesterol or are a smoker)</li><li>You have diabetes</li><li>You smoke</li><li>You have Systemic Lupus Erythematosus SLE (inflammatory, auto-immune disorder which causes symptoms such as joint pain, joint inflammation, skin rashes, fever) or any similar condition</li></ul><p>Tell your doctor if you recently had or you are going to have a surgery of the stomach or intestinal tract before taking Diclomax as diclofenac sodium can sometimes worsen wound healing in your gut after surgery.</p><p>Tell your doctor or pharmacist if you have any of these conditions because Diclomax might not be the right medicine for you.</p><p><strong>Children</strong><br />These tablets are not suitable for children aged under 12.</p><p><strong>Other medicines and Diclomax</strong><br />Some medicines can interfere with your treatment. Please tell your doctor or pharmacist if you are taking any of the following:</p><ul><li>Medicines to treat diabetes</li><li>Anticoagulants (blood thinning tablets like warfarin)</li><li>Diuretics (water tablets)</li><li>Lithium (used to treat some mental problems)</li><li>Methotrexate (for treatment of some inflammatory diseases and some cancers)</li><li>Ciclosporin and tacrolimus (used to treat some inflammatory diseases and after transplants)</li><li>Trimethoprim (a medicine used to prevent or treat urinary tract infections)</li><li>Quinolone antibiotics (for infections)</li><li>Any other NSAID or COX-2 (cyclo-oxgenase-2) inhibitor, for example aspirin or ibuprofen</li><li>Mifepristone (a medicine used to terminate pregnancy)</li><li>Cardiac glycosides (for example digoxin), used to treat heart problems</li><li>Medicines known as SSRIs (used to treat depression)</li><li>Oral steroids (an anti-inflammatory drug)</li><li>Medicines used to treat heart conditions or high blood pressure, for example beta-blockers or ACE inhibitors.</li><li>Voriconazole (a medicine used to treat fungal infections).</li><li>Phenytoin (a medicine used to treat seizures)</li><li>Colestipol/cholestyramine (used to lower cholesterol)</li></ul><p>Always tell your doctor or pharmacist about all the medicines you are taking. This means medicines you have bought yourself as well as medicines on prescription from your doctor.</p><p><strong>Diclomax with food and drink</strong><br />Take this medicine with or after food.</p><p><strong>&nbsp;Pregnancy and breast-feeding</strong></p><ul><li>Although not common, abnormalities have been reported in babies whose mothers have taken NSAIDs during pregnancy. You should not take Diclomax during the last 3 months of pregnancy as it may affect the baby&#39;s circulation.</li><li>You should advise your doctor or pharmacist if you think you might be pregnant or are up to 6 months pregnant.</li><li>Taking diclofenac sodium may make it more difficult to become pregnant. You should talk to your doctor if you are planning to become pregnant, or if you have problems getting pregnant.</li><li>You should avoid taking Diclomax whilst breast feeding.</li></ul><p><strong>Driving and using machines</strong><br />Very occasionally people have reported that diclofenac sodium have made them feel dizzy, tired or sleepy. Problems with eyesight have also been reported. If you are affected in this way, you should not drive or operate machinery.</p><p><strong>Other special warnings</strong></p><ul><li>You should take the lowest effective dose of diclofenac sodium for the shortest possible time particularly if you are underweight or elderly.</li><li>There is a small increased risk of heart attack or stroke when you are taking any medicine like diclofenac sodium. The risk is higher if you are taking high doses for a long time. Always follow the doctor&rsquo;s instructions on how much to take and how long to take it for.</li><li>If at any time while taking diclofenac sodium you experience any signs or symptoms of problems with your heart or blood vessels such as chest pain, shortness of breath, weakness or slurring of speech, contact your doctor immediately.</li><li>Whilst you are taking these medicines your doctor may want to give you a check-up from time to time.</li><li>If you have a history of stomach problems when you are taking NSAIDs, particularly if you are elderly, you must tell your doctor straight away if you notice any unusual symptoms.</li><li>Because it is an anti-inflammatory medicine, diclofenac sodium may reduce the symptoms of infection, for example, headache, and high temperature. If you feel unwell and need to see a doctor, remember to tell him or her that you are taking diclofenac sodium tablets.</li><li>These tablets are not suitable for children aged under 12.</li></ul><p><strong>Diclomax contains sodium</strong><br />Diclomax contains sodium. Each enteric-coated tablet of Diclomax 50 mg Enteric-coated Tablets contains 4.7 mg sodium. This medicine contains less than 1 mmol sodium (23 mg) per enteric-coated tablet, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The doctor will tell you how many Diclomax to take and when to take them. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>Take the tablets with or after food.</p><p>Swallow the tablets whole with a glass of water. Do not crush or chew the tablets.</p><p><strong>The recommended dose is:</strong><br /><em>Adults</em><br />75 to 150 mg daily divided into two or three doses. The number of tablets which you take will depend on the strength the doctor has given you.</p><p><em>Elderly</em><br />The lowest effective dose should be used. Your doctor may advise you to take a dose that is lower than the usual adult dose if you are elderly. Close surveillance is advisable. Your doctor may also want to check closely that the Diclomax are not affecting your stomach.</p><p><em>Children</em><br />These tablets are not suitable for children aged under 12.</p><p>The doctor may also prescribe another drug to protect the stomach to be taken at the same time, particularly if you have had stomach problems before, or if you are elderly, or taking certain other drugs as well.</p><p><strong>If you take more Diclomax than you should</strong><br />If you, or anyone else, accidentally take too much Diclomax, tell your doctor or go to your nearest hospital casualty department immediately. Take your medicine pack with you so that people can see what you have taken.</p><p>Symptoms of an overdose can include: headache, nausea (feeling sick), vomiting, abdominal pain, stomach or intestinal bleeding, rarely diarrhoea, disorientation, excitation, coma, drowsiness, dizziness, ringing in the ears, fainting, or occasionally convulsions (seizures, uncontrolled fits).</p><p><strong>If you forget to take Diclomax</strong><br />It is important that you do not miss a dose. If you forget to take a dose, take one as soon as you remember. If it is nearly time for your next dose, just take the next dose and forget about the one you missed. Do not take a double dose to make up for a forgotten tablet. Do not take more than 150 mg in 24 hours. If you have trouble remembering to take the tablets, tell your doctor or pharmacist.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong><em>Some side effects can be serious</em></strong><br /><strong>Stop taking diclofenac sodium and tell your doctor straight away if you notice:</strong></p><ul><li>Sudden and crushing chest pain (signs of myocardial infarction or heart attack)</li><li>Breathlessness, difficulty breathing when lying down, swelling of the feet or legs (signs of heart failure)</li><li>Sudden weakness or numbness in the face, arm or leg especially on one side of the body, sudden loss or disturbance of vision; sudden difficulty in speaking or ability to understand speech; sudden migraine-like headaches which happen for the first time, with or without disturbed vision. These symptoms can be an early sign of a stroke.</li><li>Stomach pain, indigestion, heartburn, wind, nausea (feeling sick) or vomiting (being sick)</li><li>Any sign of bleeding in the stomach or intestine, for example, when emptying your bowels, blood in vomit or black tarry faeces</li><li>Allergic reactions which can include skin rash, itching, bruising, painful red areas, peeling or blistering</li><li>Wheezing or shortness of breath (bronchospasm)</li><li>Swollen face, lips, hands or fingers</li><li>Yellowing of your skin or the whites of your eyes</li><li>Persistent sore throat or high temperature</li><li>An unexpected change in the amount of urine produced and/or its appearance.</li><li>Mild cramping and tenderness of the abdomen, starting shortly after the start of the treatment with diclofenac sodium and followed by rectal bleeding or bloody diarrhea usually within 24 hours of the onset of abdominal pain</li><li>Stevens Johnson syndrome (serious illnesses with blistering of the skin, mouth, eyes and genitals)</li></ul><p>If you notice that you are bruising more easily than usual or have frequent sore throats or infections, tell your doctor.</p><p>Tell your doctor immediately if you notice the following:</p><ul><li>Chest pain, which can be a sign of a potentially serious allergic reaction called Kounis syndrome</li></ul><p><strong><em>The side effects listed below have also been reported</em></strong><br /><strong>Common side effects (These may affect between 1 and 1 in 10 in every 100 patients):</strong></p><ul><li>Stomach pain, heartburn, nausea, vomiting, diarrhea, indigestion, wind, loss of appetite</li><li>Headache, dizziness, vertigo</li><li>Skin rash or spots</li><li>Raised levels of liver enzymes in the blood</li></ul><p><strong>Uncommon side effects (These may affect between 1 and 10 in every 1000 patients):</strong></p><ul><li>Fast or irregular heart beat (palpitations), chest pain, heart disorders, including heart attack or breathlessness, difficulty breathing when lying down, or swelling of the feet or legs (signs of heart failure), especially if you have been taking a higher dose (150 mg per day) for a long period of time.</li></ul><p><strong>Rare side effects (These may affect between 1 in every 1000 to 1 in every 10,000 patients):</strong></p><ul><li>Stomach ulcers or bleeding (there have been very rare reported cases resulting in death, particularly in the elderly)</li><li>Gastritis (inflammation, irritation or swelling of the stomach lining)</li><li>Vomiting blood</li><li>Diarrhoea with blood in it or bleeding from the back passage</li><li>Black, tarry faeces or stools</li><li>Drowsiness, tiredness</li><li>Skin rash and itching</li><li>Fluid retention, symptoms of which include swollen ankles</li><li>Liver function disorders, including hepatitis and jaundice</li><li>Asthma (symptoms may include wheezing, breathlessness, coughing and a tightness across the chest)</li></ul><p><strong>Very rare side effects (These may affect less than 1 in every 10,000 patients):</strong><br /><em>Effects on the nervous system:</em></p><ul><li>Inflammation of the lining of the brain (meningitis), tingling or numbness in the fingers, tremor, visual disturbances such as blurred or double vision, taste changes, hearing loss or impairment, tinnitus (ringing in the ears), sleeplessness, nightmares, mood changes, depression, anxiety, irritability, mental disorders, disorientation and loss of memory, fits, headaches together with a dislike of bright lights, fever and a stiff neck.</li></ul><p><em>Effects on the stomach and digestive system:</em></p><ul><li>Constipation, inflammation of the tongue, mouth ulcers, inflammation of the inside of the mouth or lips, \lower gut disorders (including inflammation of the colon or worsening of ulcerative colitis or Crohn&rsquo;s disease), inflammation of the pancrease.</li></ul><p><em>Effects on the chest or blood:</em></p><ul><li>Hypertension (high blood pressure), hypotension (low blood pressure, symptoms of which may include faintness, giddiness or light headedness), inflammation of blood vessels (vasculitis), inflammation of the lung (pneumonitis), blood disorders (including anaemia).</li></ul><p><em>&nbsp;Effects on the liver or kidneys:</em></p><ul><li>Kidney or severe liver disorders including liver failure, presence of blood or protein in the urine.</li></ul><p><em>Effects on skin or hair:</em></p><ul><li>Facial swelling, serious skin rashes including Stevens Johnson syndrome, Lyell&rsquo;s syndrome and other skin rashes which may be made worse by exposure to sunlight.</li><li>Hair loss.</li></ul><p><em>Effects on the reproductive system:</em></p><ul><li>Impotence.</li></ul><p><em>Other side effects that have also been reported with unknown frequency include:</em></p><ul><li>Throat disorders, confusion, hallucinations, malaise (general feeling of discomfort), inflammation of the nerves in the eye, disturbances of sensation.</li><li>Medicines such as diclofenac may be associated with a small increased risk of heart attack or stroke.</li></ul><p>Do not be alarmed by this list - most people take diclofenac sodium without any problems.</p><p>If any of the side effects becomes serious, or if you notice side effects not listed in this leaflet, please tell your doctor. He/she may want to give you a different medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Store below 30&deg;C.</p><p>Store in the original package.</p><p>Do not use this medicine after the expiry date which is stated on the package after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p><p>Do not use this medicine if you notice any visible signs of deterioration.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is diclofenac sodium.</p><p>Each enteric-coated tablet of Diclomax 50 mg Enteric-coated Tablets contains 50 mg diclofenac sodium.</p><p>The other ingredients are: <em>Tablet core:</em> Colloidal silicon dioxide, microcrystalline cellulose, croscarmellose sodium and magnesium stearate. <em>Tablet coat:</em> Talc, titanium dioxide, polyethylene glycol, simethicone emulsion, methacrylic acid copolymer, Opadry white, quinoline yellow lake and Sicopharm brown lake.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Diclomax 50 mg Enteric-coated Tablets are dark mustard biconvex enteric-coated tablets embossed with "JI" on one side and "12" on the other side in clear PVC/PVDC- aluminum blisters. 

Pack sizes: 20 and/or 160 Enteric-coated Tablets.

Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder and Manufacturer</strong><br />Jazeera Pharmaceutical Industries<br />Al-Kharj Road<br />P.O. Box 106229<br />Riyadh 11666, Saudi Arabia<br />Tel: + (966-11) 8107023, + (966-11) 2142472<br />Fax: + (966-11) 2078170<br />e-mail: SAPV@hikma.com</p><p><strong>Reporting of side effects</strong><br />If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can also help provide more information on the safety of this medicine.</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 03/2024; version number SA2.0.


            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">تنتمي المادة الفعالة ديكلوفيناك الصوديوم الموجودة في ديكلوماكس، إلى مجموعة أدوية تُسمى مضادات الالتهابات غير الستيرويدية. تعمل مضادات الالتهابات غير الستيرويدية على تقليل الألم والالتهاب.</p><p>يخفف ديكلوماكس من الألم، يقلل التورم ويُخفف الالتهابات في الحالات التي تؤثر على المفاصل والعضلات والأوتار، بما في ذلك:</p><ul dir="rtl"><li>التهاب المفاصل الروماتويدي، والالتهاب العظمي المفصلي، والنقرس الحاد (التهاب مؤلم في المفاصل خاصة في القدمين واليدين)، والتھاب الفقرات القسطي (شكل من أشكال الالتهاب المفصليّ).</li><li>ألم الظهر، والالتواءات وحالات الإجهاد، وإصابات الأنسجة الرخوة في الألعاب الرياضية، والكتف المتجمدة، وخلع العظام والكسور</li><li>الحالات التي تصيب الأوتار على سبيل المثال، التهاب الأوتار والتهاب زَليل الوتر والالتهاب الكيسي.</li></ul><p>يُستخدم الدواء أيضاً لعلاج الألم والالتهاب المرتبط بجراحات الأسنان والجراحات البسيطة.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول ديكلوماكس إذا:</strong></p><ul dir="rtl"><li>كنت تُعاني من حساسية لديكلوفيناك الصوديوم أو الأسبرين أو الإيبوبروفين أو أي من مضادات الالتهاب غير الستيرويدية الأخرى، أو أي من المكونات الأخرى لديكلوماكس (المُدرجة في القسم 6 &quot;محتويات العبوة ومعلومات إضافية&quot; من النشرة). تشمل علامات رد الفعل التحسسي المفرط تورم الوجه والفم (الوذمة الوعائية) أو مشكلات في التنفس أو ألم بالصدر أو سيلان الأنف أو طفح جلدي أو أي رد فعل تحسسي من نوع آخر.</li><li>كنت مصاباً الآن، أو في أي وقت سابق، بقرحة المعدة أو قرحة الاثنا عشر، أو في حالة وجود نزف في الجهاز الهضمي (قد يشمل ذلك وجود دم في القيء، أو نزف عند التبرز، أو وجود دم حديث في البراز أو براز أسود أو قطراني)</li><li>كنت قد عانيت من مشكلات في المعدة أو الأمعاء بعد تناول مضادات الالتهابات غير الستيرويدية الأخرى</li><li>كنت تعاني من فشل القلب أو الكلى أو الكبد</li><li>كنت تعاني من مرض في القلب و/ أو مرض وعائي دماغي، على سبيل المثال، إذا كنت قد تعرضت لأزمة قلبية، أو سكتة دماغية، أو سكتة دماغية بسيطة، أو انسدادات في الأوعية الدموية الواصلة إلى القلب أو الدماغ، أو خضعت لعملية لإزالة الانسدادات أو فتح مجرى جانبي لها.</li><li>كان لديك، أو قد واجهت، مشاكل في الدورة الدموية (مرض الشرايين الطرفية)</li><li>كنتِ حاملاً منذ أكثر من ستة أشهر</li></ul><p><strong>الاحتياطات والتحذيرات</strong><br />تحدث مع طبيبك أو الصيدلي قبل تناول ديكلوفيناك إذا:</p><ul dir="rtl"><li>كنت تعاني من أي اضطرابات في المعدة أو الأمعاء تشمل التهاب القولون التقرحي أو داء كرون</li><li>كنت تعاني من مشكلات بالكُلى أو الكبد، أو كنت مسناً</li><li>كنت تعاني من حالة تُسمى بورفيريا</li><li>كنت تعاني من أي اضطراب في الدم أو اضطراب نزفي. إذا كنت كذلك، فقد يطلب منك طبيبك الخضوع للفحوصات العادية في أثناء تناول هذه الأقراص.</li><li>عانيت في أي وقت مضى من الربو، أو حساسية الأنف الموسمية، أو تورم الغشاء المخاطي للأنف (السلائل الأنفية)، أو أمراض الرئة المزمنة أو التهابات في الجهاز التنفسي.</li><li>كنتِ ترضعين طبيعياً.</li><li>كنت تعاني من الذبحة الصدرية، أو الجلطات الدموية، أو ارتفاع ضغط الدم، أو ارتفاع مستوى الكولسترول، أو ارتفاع مستوى الجلسريدات الثلاثية</li><li>كنت تُعاني من مشكلات بالقلب أو تعرضت لسكتة دماغية أو تظن أنك معرض لخطر الإصابة بأي من هذه الحالات (على سبيل المثال، إذا كنت تُعاني مثلاً من ارتفاع ضغط الدم أو السكري أو ارتفاع مستوى الكوليسترول أو كنت مدخناً).</li><li>كنت تعاني من مرض السكري</li><li>كنت تدخن</li><li>كنت مصاباً بمرض الذئبة الحمامية المجموعية (التهاب، اضطراب المناعة الذاتية الذي يسبب أعراضاً مثل آلام المفاصل، والتهاب المفاصل، والطفح الجلدي، والحمّى) أو أي حالة مشابهة</li></ul><p dir="RTL">أخبر طبيبك إذا كنت قد أجريت مؤخراً أو ستجري جراحة في المعدة أو الجهاز الهضمي قبل تناول ديكلوماكس لأن ديكلوفيناك الصوديوم قد يؤدي أحياناً إلى تفاقم التئام الجروح في الأمعاء بعد إجراء الجراحة.</p><p>أخبر طبيبك أو الصيدلي إذا كان لديك أي من هذه الحالات لأن ديكلوماكس قد لا يكون الدواء المناسب لك.</p><p><strong>&nbsp;الأطفال&nbsp;</strong><br />هذه الأقراص ليست مناسبة للأطفال الذين تقل أعمارهم عن 12 عاماً.</p><p><strong>&nbsp;الأدوية الأخرى وديكلوماكس</strong><br />قد تتداخل بعض الأدوية مع علاجك. أخبر طبيبك أو الصيدلي إذا كنت تأخذ أيّاً مما يلي:</p><ul dir="rtl"><li>أدوية لعلاج مرض السكري</li><li>مضادات التخثر (أقراص ترقيق الدم مثل وارفارين)</li><li>مدرات البول (أقراص الماء)</li><li>الليثيوم (المستخدم في علاج بعض المشكلات النفسية)</li><li>ميثوتركسيت (المستخدم في علاج بعض الأمراض الالتهابية وبعض أنواع السرطان)</li><li>سيكلوسبورين وتاكروليمس (المستخدم في علاج بعض الأمراض الالتهابية وبعد عمليات زرع الأعضاء)</li><li>تريميثوبريم (دواء مستخدم لمنع أو علاج التهابات المسالك البولية)</li><li>مضادات الكوينولون الحيوية (لحالات العدوى)</li><li>أي مضادات التهاب غير استيرويدية أو مثبطات كوكس-2 (إنزيمات الأكسدة الحلقية-2)، مثل الأسبرين أو الإيبوبروفين</li><li>ميفيبريستون (دواء يستخدم لإجهاض الحمل)</li><li>جليكوسيدات القلب (مثل ديجوكسين)، المستخدمة لعلاج مشكلات القلب</li><li>الأدوية المعروفة بمثبطات استرداد السيروتونين (المستخدمة لعلاج الاكتئاب)</li><li>الستيرويدات الفموية (عقار مضاد للالتهاب)</li><li>الأدوية المستخدمة لعلاج حالات القلب أو ارتفاع ضغط الدم، مثل حاصرات بيتا أو مثبطات الإنزيم المحول للأنجيوتنسين</li><li>فوريكونازول (دواء يستخدم لعلاج العدوى الفطرية)</li><li>فنيتوين (دواء يستخدم لعلاج النوبات التشنجية)</li><li>كولستيبول/كولسترامين (المستخدم لخفض نسبة الكولسترول)</li></ul><p>أخبر دائماً طبيبك أو الصيدلي عن كل الأدوية التي تتناولها. ويشير هذا إلى الأدوية التي اشتريتها بنفسك بالإضافة إلى الأدوية المعتمدة على وصفة طبية من طبيبك.</p><p><strong>ديكلوماكس مع الطعام والشراب</strong><br />تناول هذا الدواء مع الطعام أو بعده.</p><p><strong>&nbsp;الحمل والرضاعة</strong></p><ul dir="rtl"><li>على الرغم من أنه أمر غير شائع، تم الإبلاغ عن حدوث تشوهات في أطفال الأمهات اللاتي كن يتناولن مضادات الالتهابات غير الستيرويدية أثناء الحمل. يجب عليكِ عدم تناول ديكلوماكس خلال آخر 3 أشهر من الحمل لأنه قد يؤثر على الدورة الدموية للجنين.</li><li>يجب عليكِ أن تخبري طبيبكِ أو الصيدلي إذا كنتِ تعتقدين أنكِ حامل أو تصل فترة حملكِ إلى 6 أشهر.</li><li>قد يقلل تناول ديكلوفيناك الصوديوم من فرص حدوث حمل. لذا يجب عليكِ استشارة الطبيب إذا كنتِ تخططين للحمل أو كانت لديك صعوبة في حدوث حمل.</li><li>يجب عليكِ تجنب تناول ديكلوماكس في أثناء الرضاعة الطبيعية.</li></ul><p><strong>&nbsp;القيادة واستخدام الآلات&nbsp;</strong><br />أبلغ الأشخاص في كثير من الأحيان أن ديكلوفيناك الصوديوم جعلهم يشعرون بالدوار والتعب والنعاس. كما تم الإبلاغ عن مشكلات في الإبصار. إذا شعرت بذلك، فيجب عليك عدم قيادة السيارة أو تشغيل الآلات.</p><p><strong>التحذيرات الخاصة الأخرى&nbsp;</strong></p><ul dir="rtl"><li>يجب أن تتناول أقل جرعة فعّالة من ديكلوفيناك الصوديوم لأقصر فترة زمنية ممكنة، خاصةً إذا كنت تعاني من نقصان الوزن أو كنت مسناً.</li><li>توجد زيادة بسيطة في خطر الإصابة بأزمة قلبية أو سكتة دماغية عندما تتناول أي دواء مثل ديكلوفيناك الصوديوم. يزداد الخطر إذا كنت تتناول جرعات عالية لفترة طويلة. اتبع دائماً تعليمات الطبيب حول المقدار الذي تتناوله والفترة الزمنية لتناوله.</li><li>إذا شعرت في أي وقت أثناء تناول ديكلوفيناك الصوديوم بأي علامات أو أعراض لمشكلات في القلب أو الأوعية الدموية مثل ألم في الصدر أو ضيق تنفس أو ضعف الكلام أو التلعثم، فاتصل بطبيبك على الفور.</li><li>قد يرغب الطبيب في فحصك من وقت لآخر خلال فترة تناولك لهذه الأدوية.</li><li>إذا سبقت إصابتك بمشكلات المعدة في أثناء تناولك مضادات الالتهابات غير الستيرويدية، خاصة إذا كنت مسناً، فيجب أن تخبر طبيبك على الفور إذا لاحظت أي أعراض غير معتادة.</li><li>نظراً لأنه دواء مضاد للالتهاب، قد يقلل ديكلوفيناك الصوديوم من أعراض العدوى، على سبيل المثال، الصداع وارتفاع درجة الحرارة. إذا شعرت بالتوعك وبالحاجة إلى زيارة الطبيب، فتذكر إخباره أنك تتناول أقراص ديكلوفيناك الصوديوم.</li><li>هذه الأقراص ليست مناسبة للأطفال دون عمر 12 عاماً.</li></ul><p><strong>يحتوي ديكلوماكس على الصوديوم&nbsp;</strong><br />يحتوي ديكلوماكس على الصوديوم. يحتوي كل قرص مغطى معوياً من ديكلوماكس 50 ملغم أقراص مغطاة معوياً على 4.7 ملغم صوديوم. يحتوي هذا الدواء على أقل من 1 ملمول صوديوم (23 ملغم) لكل قرص مغطى معوياً، وبذلك يعتبر &rsquo; خالٍ من الصوديوم&lsquo; بشكل أساسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيخبرك الطبيب بعدد مرات ومواعيد تناول ديكلوماكس. تناول هذا الدواء دائماً تماماً كما هو موصوف في هذه النشرة أو كما أخبرك طبيبك أو الصيدلي. تحقق من طبيبك أو الصيدلي إذا لم تكن متأكداً.</p><p>تناول الأقراص مع الطعام أو بعده.</p><p>ابتلع جرعة الأقراص الكاملة مع كوب من الماء لا تسحق الأقراص أو تمضغها.</p><p><strong>الجرعة الموصى بها هي:&nbsp;</strong><br /><em>البالغون&nbsp;</em><br />مقدار يتراوح بين 75 و150 ملغم يومياً مقسم إلى جرعتين أو ثلاث جرعات. يعتمد عدد الأقراص التي تتناولها على التركيز الذي حدده لك الطبيب.</p><p><em>كبار السن&nbsp;</em><br />يجب استخدام أقل جرعة فعّالة. قد ينصحك الطبيب بتناول جرعة أقل من الجرعة المعتادة للبالغين إذا كنت مسناً. يوصى بالمراقبة الدقيقة. قد يرغب طبيبك أيضاً في التحقق عن كثب من أن ديكلوماكس لا يؤثر على معدتك.</p><p><em>الأطفال&nbsp;</em><br />هذه الأقراص ليست مناسبة للأطفال دون عمر 12 عاماً.</p><p>قد يصف الطبيب أيضاً عقاراً آخر لحماية المعدة يتم تناوله في نفس الوقت، خاصة إذا كنت قد عانيت من مشكلات في المعدة في السابق، أو إذا كنت مسناً، أو تتناول عقاقير أخرى.</p><p><em>&nbsp;</em><strong>إذا تناولت ديكلوماكس أكثر من اللازم&nbsp;</strong><br />إذا حدث وتناولت، أو تناول أي شخص آخر، جرعة زائدة عن طريق الخطأ من ديكلوماكس، فأخبر طبيبك أو توجه إلى قسم الطوارئ بأقرب مستشفى على الفور. اصطحب معك عبوة دوائك حتى يعلم الأشخاص ما الدواء الذي تناولته.</p><p>يمكن أن تشمل أعراض الجرعة الزائدة: صداع، أو غثيان (شعور بالإعياء)، أو قئ، أو ألم في البطن، أو نزف في المعدة أو الأمعاء، أو إسهال نادر، أو توهان، أو سرعة انفعال، أو غيبوبة، أو نعاس، أو دوخة، أو طنين في الأذنين، أو إغماءً، أو تشنجات في بعض الأحيان (نوبات صرع أو نوبات لا يمكن التحكم بها).</p><p><strong>إذا نسيت تناول ديكلوماكس&nbsp;</strong><br />من المهم ألا تفوتك أي جرعات. في حالة نسيانك تناول جرعة، تناولها فور تذكرها. إذا تذكرتها قرب موعد الجرعة التالية، فتناول فقط الجرعة التالية وتجاهل الجرعة الفائتة. لا تقم بتناول جرعة مضاعفة لتعويض قرصاً منسياً. لا تتناول أكثر من 150 ملغم خلال 24 ساعة. إذا كانت لديك مشكلة في تذكر تناول الأقراص، أخبر طبيبك أو الصيدلي.</p><p>إذا كان لديك أية أسئلة إضافية حول استخدام هذا الدواء، اسأل الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثاراً جانبية، إلا إنه ليس بالضرورة أن تحدث لدى جميع مستخدمي هذا الدواء.</p><p><strong><em>بعض الآثار الجانبية قد تكون خطيرة&nbsp;</em></strong><br /><strong>توقف عن تناول ديكلوفيناك الصوديوم وأخبر طبيبك فوراً إذا لاحظت أياً مما يلي:</strong></p><ul dir="rtl"><li>ألم مفاجئ وشديد في الصدر (علامات احتشاء عضلة القلب أو نوبة قلبية)</li><li>ضيق التنفس، أو صعوبة في التنفس عند الاستلقاء، أو تورم في القدمين أو الساقين (علامات فشل القلب)</li><li>خدر أو ضعف مفاجئ في الوجه أو الذراع أو الساق خاصةً في جانب واحد من الجسم، أو فقدان أو اضطراب البصر المفاجئ؛ أو صعوبة مفاجئة في التحدث أو القدرة على فهم الكلام؛ أو صداع مفاجئ شبيه بالصداع النصفي يحدث لأول مرة مع أو بدون حدوث اضطراب في الرؤية. يمكن أن تكون هذه الأعراض علامة مبكرة على حدوث سكتة دماغية.</li><li>ألم بالمعدة أو عسر هضم أو حرقة معدة أو غازات أو غثيان (بشعور بالإعياء) أو قيء (إعياء)</li><li>أي علامات نزف في المعدة أو الأمعاء، على سبيل المثال، عند التبرز، أو وجود دم في القيء أو براز أسود أو قطراني</li><li>ردود الفعل التحسسية التي قد تشمل طفح جلدي أو حكة أو كدمات أو مناطق حمراء مؤلمة أو تقشر الجلد أو بثور</li><li>أزيز أو ضيق النفس (التشنج القصبي)</li><li>تورم الوجه أو الشفتين أو الأيدي أو الأصابع</li><li>اصفرار الجلد أو بياض العينين</li><li>التهاب الحلق المستمر أو ارتفاع درجة الحرارة</li><li>تغير غير متوقع في كمية البول الذي تخرجه و/أو مظهره.</li><li>تقلصات أو آلام في البطن، يحدث بعد وقت قصير من بدء العلاج بديكلوفيناك الصوديوم ويتبعها عادةً نزف في المستقيم أو إسهال دموي خلال 24 ساعة من ظهور آلام البطن</li><li>متلازمة ستيفنز جونسون (مرض خطير يصحبه تبثر الجلد، والفم، والعينين، والأعضاء التناسلية)</li></ul><p>إذا لاحظت أنك تتعرض للتكدم بشكل أسهل من المعتاد أو تصاب بالتهاب الحلق والعدوى بشكل متكرر، فأخبر طبيبك.</p><p>أخبر طبيبك على الفور إذا لاحظت ما يلي:</p><ul dir="rtl"><li>ألم في الصدر، ويمكن أن يكون أحد علامات احتمالية حدوث على رد فعل تحسسي خطير يسمى متلازمة كونس</li></ul><p><strong><em>كما تم الإبلاغ عن الآثار الجانبية المدرجة أدناه.</em></strong><br /><strong>آثار جانبية شائعة (قد تؤثر فيما يتراوح بين مريض ومريض من كل 10 مرضى من بين 100 مريض):</strong></p><ul dir="rtl"><li>ألم بالمعدة، وحرقة في المعدة، وغثيان، وقيء، وإسهال، وعسر هضم، وغازات، وفقدان شهية</li><li>صداع، ودوخة، ودوار</li><li>الطفح أو البقع الجلدية</li><li>ارتفاع مستويات إنزيمات الكبد في الدم</li></ul><p><strong>آثار جانبية غير شائعة (قد تؤثر فيما بين مريض و10 مرضى من بين 1000 مريض):</strong></p><ul dir="rtl"><li>سرعة ضربات القلب أو عدم انتظامها (خفقان)، أو ألم في الصدر، أو اضطرابات القلب، بما في ذلك النوبة القلبية أو ضيق التنفس، أو صعوبة التنفس عند الاستلقاء، أو تورم القدمين أو الساقين (علامات لفشل القلب)، خاصةً إذا كنت تتناول جرعة أعلى (150 ملغم يومياً) لفترة زمنية طويلة.</li></ul><p><strong>آثار جانبية نادرة (قد تؤثر فيما بين مريض من بين كل 1000 مريض ومريض من بين كل 10000 مريض)</strong></p><ul dir="rtl"><li>قرح المعدة أو النزف (تم الإبلاغ عن حالات نادرة جداً نتج عنها الوفاة، خاصة في كبار السن)</li><li>التهاب بطانة المعدة (التهاب أو تهيج أو تورم بطانة المعدة)</li><li>قيء دم</li><li>إسهال مع وجود دم فيه أو نزف من الشرج</li><li>براز أسود أو قطراني</li><li>النعاس، أو التعب</li><li>الطفح الجلدي والحكة</li><li>احتباس السوائل، وتشمل أعراضه تورم الكاحلين</li><li>اضطرابات وظائف الكبد، وتشمل التهاب الكبد واليرقان</li><li>الربو (قد تشمل الأعراض أزيزاً وضيق التنفس وسعالاً وضيقاً في الصدر)</li></ul><p dir="RTL"><strong>آثار جانبية نادرة جداً (قد تؤثر في أقل من مريض واحد من بين كل 10000 مريض)</strong><br /><em>التأثيرات على الجهاز العصبي:</em></p><ul dir="rtl"><li>التهاب بطانة الدماغ (التهاب السحايا)، والوخز أو التنميل في الأصابع، والرعاش، واضطرابات بصرية مثل عدم وضوح أو ازدواج الرؤية، وتغيرات في حاسة التذوق، وفقدان أو ضعف السمع (طنين في الأذنين)، والأرق، والكوابيس، والتغيرات المزاجية، والاكتئاب، والقلق، والتهيج، والاضطرابات النفسية، والتوهان، وفقدان الذاكرة، والنوبات، والصداع، إلى جانب كراهية الأضواء الساطعة، والحمى، وتصلب الرقبة.</li></ul><p><em>التأثيرات على المعدة والجهاز الهضمي:</em></p><ul dir="rtl"><li>الإمساك، والتهاب اللسان، وقرح الفم، والتهاب الجزء الداخلي من الفم أو الشفتين، واضطرابات الأمعاء (تشمل التهاب القولون أو تفاقم التهاب القولون التقرحي أو داء كرون) والتهاب البنكرياس.</li></ul><p><em>التأثيرات على الصدر أو الدم:</em></p><ul dir="rtl"><li>ارتفاع ضغط الدم، انخفاض ضغط الدم، وأعراض قد تشمل الإغماء، أو الشعور بالدوخة، أو الدوار الخفيف)، والتهاب الأوعية الدموية (الالتهاب الوعائي)، والالتهاب الرئوي، واضطرابات الدم (بما في ذلك فقر الدم).</li></ul><p><em>&nbsp;التأثيرات على الكبد أو الكُلى:</em></p><ul dir="rtl"><li>اضطرابات الكُلى أو الكبد الحادة التي تشمل الفشل الكبدي، ووجود دم أو بروتين في البول.</li></ul><p><em>التأثيرات على الجلد أو الشعر:</em></p><ul dir="rtl"><li>تورّم الوجه، وحالات خطيرة من الطفح الجلدي تشمل متلازمة ستيفنز جونسون، ومتلازمة لايل وغيرها من حالات الطفح الجلدي التي قد تسوء بالتعرض إلى أشعة الشمس.</li><li>تساقط الشعر.</li></ul><p><em>التأثيرات على الجهاز التناسلي:</em></p><ul dir="rtl"><li>الضعف الجنسي.</li></ul><p><em>تشمل الآثار الجانبية الأخرى التي تم الإبلاغ عنها ولا يُعرف مدى شيوعها ما يلي:</em></p><ul dir="rtl"><li>اضطرابات الحلق، والارتباك، والهلاوس، والإعياء (شعور عام بعدم الارتياح)، والتهاب أعصاب العين، واضطرابات حسية.</li><li>قد يُصاحب تناول أدوية مثل ديكلوفيناك زيادة طفيفة في خطر الإصابة بأزمة قلبية أو سكتة دماغية.</li></ul><p>لا تنزعج من هذه القائمة - معظم الأشخاص يتناولون ديكلوفيناك الصوديوم بدون أي مشكلات.</p><p>يرجى إخبار الطبيب في حال أصبحت أي من الآثار الجانبية خطيرة، أو في حال ظهور أية آثار جانبية لم تذكر في هذه النشرة. فقد يرغب في إعطائك دواء آخر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيداً عن مرأى ومتناول الأطفال.</p><p dir="RTL">يحفظ عند درجة حرارة أقل من 30&deg; مئوية.</p><p dir="RTL">يُحفظ داخل العبوة الأصلية.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة الخارجية بعد الاختصار &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت أي علامات تلف واضحة عليه.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه الإجراءات ستساعد في الحفاظ على سلامة البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي ديكلوفيناك الصوديوم.</p><p>يحتوي كل قرص مغطى معوياً من ديكلوماكس 50 ملغم أقراص مغطاة معوياً على 50 ملغم ديكلوفيناك صوديوم.</p><p>المواد الأخرى المستخدمة في التركيبة الصناعية هي: <em>لب القرص:</em> ثاني أكسيد السيليكون الغروي، سيلليلوز بلوري مكروي، كروسكارمیللوز الصوديوم وستيرات المغنيسيوم. <em>غلاف القرص:</em> تالك، ثاني أكسيد التيتانيوم، جليكول متعدد الإيثيلين، مستحلب السيميثيكون، بوليمر مشترك لحمض الميثاكريليك، أوبادري أبيض، صبغة كوينولين صفراء وصبغة سيكوفارم بنية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ديكلوماكس 50 ملغم أقراص مغطاة معوياً هي أقراص محدبة الوجهين بلون الخردل الداكن مغطاة معوياً، منقوش &quot;JI&quot; على أحد وجهيها و&quot;12&quot; على الوجه الآخر في أشرطة من كلوريد متعدد الڤينيل/ثنائي كلوريد متعدد الڤينيليدين-الألومنيوم. &nbsp;</p><p>أحجام العبوات: 20 و/أو 160 قرص مغطى معوياً.</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك رخصة التسويق والشركة المصنعة&nbsp;</strong><br />شركة الجزيرة للصناعات الدوائية<br />طريق الخرج<br />صندوق بريد 106229<br />الرياض 11666، المملكة العربية السعودية<br />هاتف: 8107023 (11-966) +، 2142472 (11-966) +<br />فاكس: 2078170 (11-966) +<br />البريد الإلكتروني: SAPV@hikma.com</p><p dir="RTL"><strong>للإبلاغ عن الآثار الجانبية&nbsp;</strong><br />تحدث إلى الطبيب، الصيدلي، أو الممرض إذا عانيت من أية آثار جانبية. وذلك يشمل أي آثار جانبية لم يتم ذكرها في هذه النشرة. كما أنه يمكنك الإبلاغ عن هذه الآثار مباشرةً (انظر التفاصيل المذكورة أدناه). من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة بتوفير معلومات مهمة عن سلامة الدواء.</p><ul dir="rtl"><li>المملكة العربية السعودية</li></ul><p dir="RTL">المركز الوطني للتيقظ الدوائي&nbsp;<br />مركز الاتصال الموحد: 19999<br />البريد الإلكتروني: npc.drug@sfda.gov.sa<br />الموقع الإلكتروني: &nbsp;https://ade.sfda.gov.sa</p><ul dir="rtl"><li>دول الخليج العربي الأخرى</li></ul><p dir="RTL">الرجاء الاتصال بالجهات الوطنية في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة بتاريخ 03/2024؛ رقم النسخة SA2.0.


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Diclomax 50 mg Enteric-coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each enteric-coated tablet of Diclomax 50 mg enteric-coated tablet contains 50 mg diclofenac sodium. 

Excipient(s) with known effect: Sodium.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Enteric-coated Tablets.

Dark mustard biconvex enteric-coated tablets embossed with “JI” on one side and "12" on the other side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Adults and elderly</strong><br />Relief of all grades of pain and inflammation in a wide range of conditions, including:</p><ol><li>Arthritic conditions: rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout,</li><li>Acute musculo-skeletal disorders such as periarthritis (for example frozen shoulder), tendinitis, tenosynovitis, bursitis,</li><li>Other painful conditions resulting from trauma, including fracture, low back pain, sprains, strains, dislocations, orthopaedic, dental and other minor surgery.</li></ol><p><strong>Children</strong><br />Diclofenac Sodium 50 mg tablets are not suitable for children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong><br />Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).</p><p>Adults: 75 mg to 150 mg daily in two or three divided doses.<br />The recommended maximum daily dose of diclofenac sodium is 150mg.</p><p><strong>Special populations<br /><em>Elderly</em></strong>:<br />Although the pharmacokinetics of Diclofenac sodium are not impaired to any clinically relevant extent in elderly patients, nonsteroidal anti-inflammatory drugs should be used with particular caution in such patients who generally are more prone to adverse reactions. In particular it is recommended that the lowest effective dosage be used in frail elderly patients or those with a low body weight (see also precautions) and the patient should be monitored for GI bleeding during NSAID therapy.</p><p><strong><em>Cardiovascular and significant cardiovascular risk factors</em></strong><br />Diclofenac is contraindicated in patients with established congestive heart failure (NYHA II-IV), ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease (see section 4.3 Contraindications).</p><p>Patients with congestive heart failure (NYHA-I) or significant risk factors for cardiovascular disease should be treated with diclofenac only after careful consideration. Since cardiovascular risks with diclofenac may increase with dose and duration of exposure, the lowest effective daily dose should be used and for the shortest duration possible (see section 4.4 Special warnings and precautions for use).</p><p><strong><em>Renal impairment</em></strong><br />Diclofenac is contraindicated in patients with renal failure (see section 4.3 Contraindications). No specific studies have been carried out in patients with renal impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering diclofenac to patients with mild to moderate renal impairment (see section 4.4 Special warnings and precautions for use).</p><p><strong><em>Hepatic impairment</em></strong><br />Diclofenac is contraindicated in patients with hepatic failure (see section 4.3 Contraindications).</p><p>No specific studies have been carried out in patients with hepatic impairment, therefore, no specific dose adjustment recommendations can be made. Caution is advised when administering diclofenac to patients with mild to moderate hepatic impairment (see section 4.4 Special warnings and precautions for use).</p><p><strong><em>Paediatric population:</em></strong><br />Diclofenac Sodium 50 mg tablets are not suitable for children.</p><p><u>Method of administration</u><br />For oral administration.</p><p>To be taken whole with liquid, preferably with or after food.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
• Active, or gastric or intestinal ulcer, bleeding or perforation.
• History of gastrointestinal bleeding or perforation, relating to previous NSAIDs therapy.
• Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
• Last trimester of pregnancy (see section 4.6)
• Hepatic failure
• Renal failure
• Established congestive heart failure (NYHA-II-IV), ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease.
• Like other non-steroidal anti-inflammatory drugs (NSAIDs), diclofenac is also contraindicated in patients in whom attacks of asthma, angiodema, urticaria or acute rhinitis are precipitated by ibuprofen, acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>General</em><br />Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2, and GI and cardiovascular risks below).</p><p>The concomitant use of diclofenac with systemic NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided due to the absence of any evidence demonstrating synergistic benefits and the potential for additive undesirable effects (see section 4.5).</p><p>Caution is indicated in the elderly on basic medical grounds. In particular, it is recommended that the lowest effective dose be used in frail elderly patients or those with a low body weight (see section 4.2).</p><p>As with other nonsteroidal anti-inflammatory drugs including diclofenac, allergic reactions, including anaphylactic/anaphylactoid reactions, can also occur without earlier exposure to the drug (see section 4.8). Hypersensitivity reactions can also progress to Kounis syndrome, a serious allergic reaction that can result in myocardial infarction. Presenting symptoms of such reactions can include chest pain occurring in association with an allergic reaction to diclofenac.</p><p>Like other NSAIDs, diclofenac may mask the signs and symptoms of infection due to its pharmacodynamic properties.</p><p>This medicine contains lactose and therefore is not recommended for patients with rare hereditary problems of galactose intolerance, severe lactase deficiency or glucose-galactose malabsorption.</p><p><em>Gastrointestinal effects</em><br />Gastrointestinal bleeding (haematemesis, melaena), ulceration or perforation, which can be fatal has been reported with all NSAIDs including diclofenac, and may occur at any time during treatment, with or without warning symptoms or a previous history of serious gastrointestinal (GI) events. They generally have more serious consequences in the elderly. If gastrointestinal bleeding or ulceration occurs in patients receiving diclofenac, the medicinal product should be withdrawn.</p><p>As with all NSAIDs, including diclofenac, close medical surveillance is imperative and particular caution should be exercised when prescribing diclofenac in patients with symptoms indicative of gastrointestinal disorders or with a history suggestive of gastric or intestinal ulceration, bleeding or perforation (see section 4.8). The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses including diclofenac and in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation.</p><p>The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal (see section 4.2).</p><p>To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation, and in the elderly, the treatment should be initiated and maintained at the lowest effective dose.</p><p>Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors ) should be considered for these patients, and also for patients requiring concomitant use of medicinal products containing low dose acetylsalicylic acid (ASA/aspirin), or other medicinal products likely to increase gastrointestinal risk (see below and section 4.5).</p><p>Patients with a history of GI toxicity, particularly the elderly, should report any unusual abdominal symptoms (especially GI bleeding).</p><p>Caution is recommended in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as systemic corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors (SSRIs) or anti-platelet agents such as acetylsalicylic acid (see section 4.5).</p><p>Close medical surveillance and caution should also be exercised in patients with ulcerative colitis or Crohn&#39;s disease, as their condition may be exacerbated (see section 4.8).</p><p>NSAIDs, including diclofenac, may be associated with increased risk of gastro-intestinal anastomotic leak. Close medical surveillance and caution are recommended when using diclofenac after gastro-intestinal surgery.</p><p><em>Hepatic impairment</em><br />Close medical surveillance is required when prescribing diclofenac to patients with impairment of hepatic function, as their condition may be exacerbated.</p><p>As with other NSAIDs, including diclofenac, values of one or more liver enzymes may increase. During prolonged treatment with diclofenac, regular monitoring of hepatic function is indicated as a precautionary measure.</p><p>If abnormal liver function tests persist or worsen, clinical signs or symptoms consistent with liver disease develop, or if other manifestations occur ( eosinophilia, rash), diclofenac should be discontinued.</p><p>Hepatitis may occur with diclofenac without prodromal symptoms.</p><p>Caution is called for when using diclofenac in patients with hepatic porphyria, since it may trigger an attack.</p><p><em>Renal impairment</em><br />As fluid retention and oedema have been reported in association with NSAID therapy, including diclofenac, particular caution is called for in patients with impaired cardiac or renal function, history of hypertension, the elderly, patients receiving concomitant treatment with diuretics or medicinal products that can significantly impact renal function, and in those patients with substantial extracellular volume depletion from any cause, e.g. before or after major surgery (see 4.3). Monitoring of renal function is recommended as a precautionary measure when using diclofenac in such cases. Discontinuation of therapy is usually followed by recovery to the pre-treatment state.</p><p><em>Skin effects</em><br />Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including diclofenac (see section 4.8). Patients appear to be at highest risk for these reactions early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Diclofenac sodium tablets should be discontinued at the first appearance of skin rash, mucosal lesions or any other signs of hypersensitivity.</p><p><em>SLE and mixed connective tissue disease</em><br />In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (see section 4.8).</p><p><em>Cardiovascular and cerebrovascular effects</em><br />Patients with congestive heart failure (NYHA-1) or patients with significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with diclofenac after careful consideration. As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient&#39;s need for symptomatic relief and response to therapy should be re-evaluated periodically.</p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and congestive heart failure (NYHA-1) as fluid retention and oedema have been reported in association with NSAID therapy including diclofenac.</p><p>Clinical trial and epidemiological data consistently point towards increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high dose (150mg daily) and in long term treatment.</p><p>Patients should remain alert for the signs and symptoms of serious arteriothrombotic events (e.g. chest pain, shortness of breath, weakness, slurring of speech), which can occur without warnings. Patients should be instructed to see a physician immediately in case of such an event.</p><p><em>Haematological effects</em><br />During prolonged treatment with diclofenac, as with other NSAIDs, monitoring of the blood count is recommended.</p><p>Diclofenac may reversibly inhibit platelet aggregation (see anticoagulants in section 4.5). Patients with defects of haemostasis, bleeding diathesis or haematological abnormalities should be carefully monitored.</p><p><em>Pre-existing asthma</em><br />In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract (especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma exacerbations (so-called intolerance to analgesics / analgesics-asthma), Quincke&#39;s oedema or urticaria are more frequent than in other patients. Therefore, special precaution is recommended in such patients (readiness for emergency). This is applicable as well for patients who are allergic to other substances, e.g. with skin reactions, pruritus or urticaria.</p><p>Like other drugs that inhibit prostaglandin synthetase activity, diclofenac sodium and other NSAIDs can precipitate bronchospasm if administered to patients suffering from, or with a previous history of bronchial asthma.</p><p><strong>Female fertility:</strong><br />The use of Diclofenac may impair female fertility and is not recommended in women attempting to conceive. In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of Diclofenac should be considered (see section 4.6).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following interactions include those observed with diclofenac gastro-resistant tablets and/or other pharmaceutical forms of diclofenac.</p><p>Lithium: If used concomitantly, diclofenac may raise plasma concentrations of lithium. Monitoring of the serum lithium level is recommended.</p><p>Digoxin: If used concomitantly, diclofenac may raise plasma concentrations of digoxin. Monitoring of the serum digoxin level is recommended.</p><p>Diuretics and Anti-hypertensive agents: Like other NSAIDs, concomitant use of diclofenac with diuretics or antihypertensive agents (e.g. beta-blockers, angiotensin converting enzyme (ACE) inhibitors) may cause a decrease in their antihypertensive effect via inhibition of vasodilatory prostaglandin synthesis.</p><p>Therefore, the combination should be administered with caution and patients, especially the elderly, should have their blood pressure periodically monitored. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy and periodically thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of nephrotoxicity.</p><p><em>Drugs known to cause hyperkalemia:</em>&nbsp;Concomitant treatment with potassium-sparing diuretics, ciclosporin, tacrolimus or trimethoprim may be associated with increased serum potassium levels, which should therefore be monitored frequently (see section 4.4).</p><p><em>Anticoagulants and anti-platelet agents</em>: Caution is recommended since concomitant administration could increase the risk of bleeding (see section 4.4). Although clinical investigations do not appear to indicate that diclofenac affects the action of anticoagulants, there are reports of an increased risk of haemorrhage in patients receiving diclofenac and anticoagulants concomitantly (see section 4.4). Therefore, to be certain that no change in anticoagulant dosage is required, close monitoring of such patients is required. As with other nonsteroidal anti-inflammatory agents, diclofenac in high dose can reversibly inhibit platelet aggregation.</p><p><em>Other NSAIDS including cyclo-oxygenase-2selective inhibitors and corticosteroids</em>: Co-administration of diclofenac and other systemic NSAIDs or corticosteroids may increase the risk of gastrointestinal bleeding or ulceration. Avoid concomitant use of two or more NSAIDs (see section 4.4).</p><p><em>Selective serotonin reuptake inhibitors (SSRIs):</em>&nbsp;Concomitant administration of SSRIs may increase the risk of gastrointestinal bleeding (see section 4.4).</p><p><em>Antidiabetics</em>:<strong>&nbsp;</strong>Clinical studies have shown that diclofenac can be given together with oral antidiabetic agents without influencing their clinical effect. However, there have been isolated reports of hypoglycaemic and hyperglycaemic effects necessitating changes in the dosage of the antidiabetic agents during treatment with diclofenac. For this reason, monitoring of the blood glucose level is recommended as a precautionary measure during concomitant therapy.</p><p><em>Methotrexate</em>: Diclofenac can inhibit the tubular renal clearance of methotrexate hereby increasing methotrexate levels. Caution is recommended when NSAIDs, including diclofenac, are administered less than 24 hours before treatment with methotrexate, since blood concentrations of methotrexate may rise and the toxicity of this substance be increased.</p><p>Cases of serious toxicity have been reported when methotrexate and NSAIDs including diclofenac are given within 24 hours of each other. This interaction is mediated through accumulation of methotrexate resulting from impairment of renal excretion in the presence of the NSAID.</p><p><em>Ciclosporin</em>: Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin due to the effect on renal prostaglandins. Therefore, it should be given at doses lower than those that would be used in patients not receiving ciclosporin.</p><p><em>Tacrolimus:</em>&nbsp;Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus. This might be mediated through renal antiprostagladin effects of both NSAID and calcineurin inhibitor.</p><p><em>Quinolone antimicrobials:</em>&nbsp;Convulsions may occur due to an interaction between quinolones and NSAIDs. This may occur in patients with or without a previous history of epilepsy or convulsions. Therefore, caution should be exercised when considering the use of a quinolone in patients who are already receiving an NSAID.</p><p><em>Phenytoin</em>: When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin.</p><p><em>Colestipol and cholestyramine</em>: These agents can induce a delay or decrease in absorption of diclofenac. Therefore, it is recommended to administer diclofenac at least one hour before or 4 to 6 hours after administration of colestipol/ cholestyramine.</p><p><em>Cardiac glycosides:</em>&nbsp;Concomitant use of cardiac glycosides and NSAIDs in patients may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.</p><p><em>Mifepristone</em>: NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.</p><p><em>Potent CYP2C9 inhibitors</em><strong>:&nbsp;</strong>&ldquo;Caution is recommended when co-prescribing diclofenac with potent CYP2C9 inhibitors (such as sulfinpyrazone and voriconazole), which could result in a significant increase in peak plasma concentration and exposure to diclofenac due to inhibition of diclofenac metabolism.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy:</strong><br />Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1%, up to approximately 1.5 %.</p><p>The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has been shown to result in increased pre- and post-implantation loss and embryo-foetal lethality.</p><p>In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during the organogenetic period. If diclofenac is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to:</p><ul><li>Cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension);</li><li>Renal dysfunction, which may progress to renal failure with oligo-hydroamniosis; the mother and the neonate, at the end of pregnancy, to:</li><li>Possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses.</li><li>Inhibition of uterine contractions resulting in delayed or prolonged labour.</li></ul><p>Consequently, diclofenac sodium tablets are contraindicated during the third trimester of pregnancy.</p><p><em>Breast-feeding:</em><br />Like other NSAIDs, diclofenac passes into the breast milk in small amounts. Therefore, diclofenac should not be administered during breast feeding in order to avoid undesirable effects in the infant (see section 5.2).</p><p><em>Femaile Fertility</em><br />As with other NSAIDs, the use of diclofenac may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of diclofenac should be considered (see also section 4.4 regarding female fertility).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients who experience visual disturbances, dizziness, vertigo, somnolence central nervous system disturbances, drowsiness or fatigue while taking NSAIDs should refrain from driving or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse reactions (Table 1) are ranked under heading of frequency, the most frequent first, using the following convention: very common: (&gt;1/10); common (&ge;1/100, &lt;1/10); uncommon (&ge;1/1,000, &lt;1/100); rare (&ge;1/10,000, &lt;1/1,000); very rare (&lt;1/10,000); Not known: cannot be estimated from the available data.</p><p>The following undesirable effects include those reported with either short-term or long-term use.</p><p><strong>Table 1</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Thrombocytopenia, leucopoenia, anaemia (including haemolytic and aplastic anaemia), agranulocytosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Hypersensitivity, anaphylactic and anaphylactoid reactions (including hypotension and shock).</p><p>Angioneurotic oedema (including face oedema).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Disorientation, depression, insomnia, nightmare, irritability, psychotic disorder.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p><p>Unknown</p></td><td style="vertical-align:top"><p>Headache, dizziness.</p><p>Somnolence, tiredness.</p><p>Paraesthesia, memory impairment, convulsion, anxiety, tremor, aseptic meningitis, taste disturbances, cerebrovascular accident.</p><p>Confusion, hallucinations, disturbances of sensation, malaise.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p><p>Unknown</p></td><td style="vertical-align:top"><p>Visual disturbance, vision blurred, diplopia.</p><p>Optic neuritis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Very rare</p></td><td style="vertical-align:top"><p>Vertigo.</p><p>Tinnitus, hearing impaired.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon*</p><p>Unknown</p></td><td style="vertical-align:top"><p>Myocardial infarction, cardiac failure, palpitations, chest pain.</p><p>Kounis syndrome</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hypertension, hypotension, vasculitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Asthma (including dyspnoea).</p><p>Pneumonitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p><p>Unknown</p></td><td style="vertical-align:top"><p>Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, flatulence, anorexia.</p><p>Gastritis, gastrointestinal haemorrhage, haematemesis, diarrhoea haemorrhagic, melaena, gastrointestinal ulcer with or without bleeding or perforation (sometimes fatal particularly in the elderly)..</p><p>Colitis (including haemorrhagic colitis and exacerbation of ulcerative colitis or Crohn&#39;s disease), constipation, stomatitis (including ulcerative stomatitis), glossitis, oesophageal disorder, diaphragm-like intestinal strictures, pancreatitis.</p><p>Ischaemic colitis</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Transaminases increased.</p><p>Hepatitis, jaundice, liver disorder.</p><p>Fulminant hepatitis, hepatic necrosis, hepatic failure.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>Rare</p><p>Very rare</p></td><td style="vertical-align:top"><p>Rash.</p><p>Urticaria.</p><p>Bullous eruptions, eczema, erythema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), dermatitis exfoliative, loss of hair, photosensitivity reaction, purpura , allergic purpura, pruritus.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Acute renal failure, haematuria, proteinuria, nephrotic syndrome, interstitial nephritis, renal papillary necrosis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Impotence</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Oedema</p></td></tr></tbody></table><p>The frequency reflects data from long-term treatment with a high dose (150mg/day).</p><p>Clinical trial and epidemiological data consistently point towards an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high dose (150 mg daily) and in long term treatment (see sections 4.3 and 4.4).</p><p><strong>Reporting of suspected adverse reactions</strong><br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions &lt;via:</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Symptoms</em><br />There is no typical clinical picture resulting from diclofenac over dosage. Over dosage can cause symptoms such as headache, nausea, vomiting, epigastric pain, gastrointestinal haemorrhage, diarrhoea, dizziness, disorientation, excitation, coma, drowsiness, tinnitus, fainting or convulsions. In the case of significant poisoning acute renal failure and liver damage are possible.</p><p><em>Therapeutic measures</em><br />Management of acute poisoning with NSAIDs, including diclofenac, essentially consists of supportive measures and symptomatic treatment. Supportive measures and symptomatic treatment should be given for complications such as hypotension, renal failure, convulsions, gastrointestinal disorder, and respiratory depression.</p><p>Special measures such as forced diuresis, dialysis or haemo-perfusion are probably of no help in eliminating NSAIDs, including diclofenac, due to the high protein binding and extensive metabolism.</p><p>Activated charcoal may be considered after ingestion of a potentially toxic overdose, and gastric decontamination (e.g. vomiting, gastric lavage) after ingestion of a potentially life threatening overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Pharmacotherapeutic group</em><br />Non-steroidal anti-inflammatory drugs (NSAlDs).</p><p><strong><em>Mechanism of action</em></strong><br />Diclofenac sodium is a non-steroidal agent with marked analgesic/anti inflammatory properties. It is an inhibitor of prostaglandin synthetase, (cyclo-oxygenase).</p><p>Diclofenac sodium in vitro does not suppress proteoglycan biosynthesis in cartilage at concentrations equivalent to the concentrations reached in human beings.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong><br />Absorption is complete but onset is delayed until passage through the stomach, which may be affected by food which delays stomach emptying. The mean peak plasma diclofenac concentration reached at about 2 hours (50mg dose produces 1511&plusmn; 466 ng/ml).</p><p><strong>Bioavailability</strong><br />About half of the administered diclofenac is metabolised during its first passage through the liver (&quot;first-pass&quot; effect), the area under the concentrations curve (AUC) following oral administration is about half that following an equivalent parenteral dose.</p><p>Pharmacokinetic behaviour does not change on repeated administration. Accumulation does not occur, provided the recommended dosage intervals are observed.</p><p><strong>Distribution</strong><br />The active substance is 99.7% protein bound, mainly to albumin (99.4%).</p><p>Diclofenac enters the synovial fluid, where maximum concentrations are measured 2-4 hours after the peak plasma values have been attained. The apparent half-life for elimination from the synovial fluid is 3-6 hours. Two hours after reaching the peak plasma values, concentrations of the active substance are already higher in the synovial fluid than they are in the plasma and remain higher for up to 12 hours.</p><p>Diclofenac was detected in a low concentration (100 ng/mL) in breast milk in one nursing mother. The estimated amount ingested by an infant consuming breast milk is equivalent to a 0.03 mg/kg/day dose (see section 4.6).</p><p><strong>Elimination</strong><br />The total systemic clearance of diclofenac in plasma is 263 &plusmn; 56 mL/min (mean value &plusmn; SD). The terminal half-life in plasma is 1-2 hours. Four of the metabolites, including the two active ones, also have short plasma half-lives of 1-3 hours.</p><p>About 60% of the administered dose is excreted in the urine in the form of the glucuronide conjugate of the intact molecule and as metabolites, most of which are also converted to glucuronide conjugates. Less than 1% is excreted as unchanged substance. The rest of the dose is eliminated as metabolites through the bile in the faeces.</p><p><strong>Characteristics in patients</strong><br /><em>Elderly:</em> No relevant age-dependent differences in the drug&#39;s absorption, metabolism, or excretion have been observed, other than the finding that in five elderly patients, a 15 minute iv infusion resulted in 50% higher plasma concentrations than expected with young healthy subjects.</p><p><em>Patients with renal impairment:</em>&nbsp;In patients suffering from renal impairment, no accumulation of the unchanged active substance can be inferred from the single-dose kinetics when applying the usual dosage schedule. At a creatinine clearance of less than 10 mL/min, the calculated steady-state plasma levels of the hydroxy metabolites are about 4 times higher than in normal subjects. However, the metabolites are ultimately cleared through the bile.</p><p><em>Patients with hepatic impairment:</em>&nbsp;In patients with chronic hepatitis or non-decompensated cirrhosis, the kinetics and metabolism of diclofenac are the same as in patients without liver disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Tablet core:</em><br />-&nbsp;&nbsp; Colloidal silicon dioxide<br />-&nbsp;&nbsp; Microcrystalline cellulose<br />-&nbsp;&nbsp; Croscarmellose sodium<br />-&nbsp;&nbsp; Magnesium stearate.</p><p><em>Tablet coat:</em><br />-&nbsp;&nbsp; Talc<br />-&nbsp;&nbsp; Titanium dioxide<br />-&nbsp;&nbsp; Polyethylene glycol<br />-&nbsp;&nbsp; Simethicone emulsion<br />-&nbsp;&nbsp; Methacrylic acid copolymer<br />-&nbsp;&nbsp; Opadry white<br />-&nbsp;&nbsp; Quinoline yellow lake<br />-&nbsp;&nbsp; Sicopharm brown lake.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p><p>Store in the original package.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clear PVC/PVDC- aluminum blisters.</p><p>Pack sizes: 20 and/or 160 Enteric-coated tablets.</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries
Al-Kharj Road 
P.O. Box 106229
Riyadh 11666, Saudi Arabia
Tel: + (966-11) 8107023, + (966-11) 2142472
Fax: + (966-11) 2078170
e-mail: SAPV@hikma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                11 March 2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>